What is the ticker symbol for Cardiol Therapeutics?

Cardiol Therapeutics trades under the ticker CRDL on NASDAQ.

What sector does Cardiol Therapeutics operate in?

Cardiol Therapeutics is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze CRDL in a portfolio?

PortView shows CRDL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Cardiol Therapeutics (CRDL) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$2.13-1.16%

1-year price historyRange $0.93 – $2.15

52-week range$2.13

$0.88$2.28

What Cardiol Therapeutics does

Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading candidate, CardiolRx, is currently undergoing a multi-national, randomized, double-blind, placebo-controlled Phase II/III study. This pivotal trial assesses CardiolRx's safety and effectiveness as a cardioprotective treatment to diminish cardiovascular and respiratory complications in hospitalized COVID-19 patients, while also investigating its potential for acute myocarditis. Furthermore, the company is developing a subcutaneous version of CardiolRx, aimed at addressing the cardiac fibrosis and inflammation linked to the onset and progression of heart failure. Cardiol Therapeutics Inc. was established in 2017 and operates from its headquarters in Oakville, Canada.

Key metrics

Market cap

$244.95M

P/E (TTM)

-8.47

EPS (TTM)

$-0.25

Beta

0.47

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.39

200-day avg

$1.19

52-week high

$2.28

52-week low

$0.88

CEO

David G. Elsley

ETFs linked to CRDL

Broad-market and Healthcare sector ETFs an investor holding Cardiol Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CRDL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CRDL in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Cardiol Therapeutics?: Cardiol Therapeutics trades under the ticker CRDL on NASDAQ.
Which exchange is CRDL listed on?: CRDL is listed on NASDAQ.
What sector does Cardiol Therapeutics operate in?: Cardiol Therapeutics is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze CRDL in a portfolio?: PortView shows CRDL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.